Global Rheumatoid Arthritis Market Size To Grow USD 6.9 Billion By 2030 | CAGR of 3.2%
March 15, 2023 12:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , March 15, 2023 (GLOBE NEWSWIRE) -- The Global Rheumatoid Arthritis Market Size to grow from USD 6.1 billion in 2021 to USD 6.9 billion by 2030, at a Compound Annual Growth...
The Arthritis Therapeutics Market Is Estimated To Grow 1.5x During By 2027: Fact.MR Analysis
March 06, 2023 14:00 ET
|
FACT.MR
Rockville , March 06, 2023 (GLOBE NEWSWIRE) -- The global arthritis therapeutics market would expand 1.5 times from 2020 to 2027. Patients in Europe and North America would push demand for...
[Trending] Global Rheumatoid Arthritis Drugs Market Size & Share to Hit $ 70.1 Billion by 2030 at a 1.75% CAGR: Growing cases of rheumatoid arthritis to propel market demand- Facts & Factors
February 10, 2023 04:10 ET
|
Facts & Factors
SAN FRANCISCO, U.S., Feb. 10, 2023 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled “Rheumatoid Arthritis Drugs Market Size, Share, Growth Analysis Report By...
Autoinjectors Market to hit USD 186 billion by 2032, says Global Market Insights Inc.
February 01, 2023 03:10 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Feb. 01, 2023 (GLOBE NEWSWIRE) -- The autoinjectors market value is poised to exceed USD 186 billion by 2032, according to a new research report by Global Market Insights...
Global Companion Animal Arthritis Market Expected to Garner $5,520.5 Million in the 2022-2031 Timeframe, Growing at 7.0% CAGR [250-Pages] | Released by Research Dive
January 23, 2023 09:03 ET
|
Research Dive
New York, USA, Jan. 23, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Research Dive, the global companion animal arthritis market is predicted to rise at a tremendous CAGR of...
Palmetto Infusion, leading infusion provider in southeast, opens first clinic in Florida
December 05, 2022 10:23 ET
|
Palmetto Infusion
Panama City, Florida, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Palmetto Infusion, the leading ambulatory infusion provider in the southeast, today announces a new clinic opening in Panama City—the first in...
Exagen Announces Appointment of Andrew L. Concoff MD, FACR, CAQSM, as Chief Innovation Officer
October 04, 2022 08:25 ET
|
Exagen Inc.
SAN DIEGO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced the appointment of Andrew L. Concoff M.D. FACR, CAQSM as...
Arthroscopy Devices Market Worth $9.85Bn, Globally, by 2028 at 8.1% CAGR - Exclusive Report by The Insight Partners
May 23, 2022 08:44 ET
|
The Insight Partners
New York, May 23, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Arthroscopy Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product...
Biosimilars in Immunology Prescriber Opinions Survey 2021 - Factors Influencing Choice of Prescribed Biosimilar Brands
January 20, 2022 05:58 ET
|
Research and Markets
Dublin, Jan. 20, 2022 (GLOBE NEWSWIRE) -- The "Prescriber Opinions on Biosimilars in Immunology" report has been added to ResearchAndMarkets.com's offering. This report covers the 7MM (United...
Exagen Inc. and Queen Mary University of London Announce Exclusive License and Collaboration to Develop Novel Patented Molecular Signatures for Rheumatoid Arthritis Biologic Therapeutic Selection
January 09, 2022 12:00 ET
|
Exagen Inc.
SAN DIEGO, Jan. 09, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, and Queen Mary University of London, announced today the execution of a...